2.85 0.06 (2.15%)
3:59 PM ET 11/24/09
Company Profile
Price and Volume
Recent Price 2.79
52 Week High 3.80
52 Week Low 1.03
Avg. Daily Vol. (Mil) 0.23
Beta (3 year) 1.18
Share Related Items
Mkt Cap (Mil) 138.41
Shares Out (Mil) 49.61
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.10
Current Ratio 3.20
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 20.85
Price/Cash Flow -12.20
Per Share Data
Earnings -0.24
Sales 0.00
Book Value 0.13
Cash Flow -0.23
Business Summary
A development stage pharmaceutical company, which is focused its research and development efforts on the development of REOLYSIN, its potential cancer therapeutic.
General Information
1167 Kensington Crescent NW
Suite 210
Calgary, Alberta, T2N 1X7
www.oncolyticsbiotech.com
Industry : Drugs
Sector: Health Care
Employees: 16
CEO: Dr. Bradley G. Thompson,
Short Interest
Current Month (Mil) 0.19
Previous Month (Mil) 0.13
Short Interest Ratio (Days) 0.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -121.50
Return on Investments -174.00
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
Dow Jones S&P 500 NASDAQ 10-Year Note
10,433.71 1,105.65 2,169.18 33.17
Oil *
76.42
DOWN
17.24
DOWN
0.59
DOWN
6.83
DOWN
0.47
10 Yr
3.32%
SPDR Gold
114.73
-0.16%
-0.05%
-0.31%
-1.40%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services